These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 32224751)

  • 21. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study.
    O'Donnell MJ; Chin SL; Rangarajan S; Xavier D; Liu L; Zhang H; Rao-Melacini P; Zhang X; Pais P; Agapay S; Lopez-Jaramillo P; Damasceno A; Langhorne P; McQueen MJ; Rosengren A; Dehghan M; Hankey GJ; Dans AL; Elsayed A; Avezum A; Mondo C; Diener HC; Ryglewicz D; Czlonkowska A; Pogosova N; Weimar C; Iqbal R; Diaz R; Yusoff K; Yusufali A; Oguz A; Wang X; Penaherrera E; Lanas F; Ogah OS; Ogunniyi A; Iversen HK; Malaga G; Rumboldt Z; Oveisgharan S; Al Hussain F; Magazi D; Nilanont Y; Ferguson J; Pare G; Yusuf S;
    Lancet; 2016 Aug; 388(10046):761-75. PubMed ID: 27431356
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lifestyle and risk factor modification for reduction of atrial fibrillation: We could do more.
    Guo Y; Lip GYH; Lane DA
    Trends Cardiovasc Med; 2020 Aug; 30(6):387-388. PubMed ID: 32276083
    [No Abstract]   [Full Text] [Related]  

  • 23. Atrial fibrillation: a moving target.
    Eckstein J; Conen D; Kühne M
    Swiss Med Wkly; 2014; 144():w14078. PubMed ID: 25539064
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Update on the management of atrial fibrillation.
    Amerena JV; Walters TE; Mirzaee S; Kalman JM
    Med J Aust; 2013 Nov; 199(9):592-7. PubMed ID: 24182224
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Benefits and risks of oral anticoagulation for stroke prevention in nonvalvular atrial fibrillation.
    Garcia DA
    Thromb Res; 2012 Jan; 129(1):9-16. PubMed ID: 22018997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antithrombotic therapies for stroke prevention in atrial fibrillation.
    Economides Muñoz C; Singh BN
    Minerva Cardioangiol; 2004 Apr; 52(2):125-39. PubMed ID: 15194994
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel Oral Anticoagulants for Primary Stroke Prevention in Hypertrophic Cardiomyopathy Patients With Atrial Fibrillation.
    Lee HJ; Kim HK; Jung JH; Han KD; Lee H; Park JB; Kim HM; Kim YJ; Ommen SR
    Stroke; 2019 Sep; 50(9):2582-2586. PubMed ID: 31340730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Focused 2012 update of the Canadian Cardiovascular Society atrial fibrillation guidelines: recommendations for stroke prevention and rate/rhythm control.
    Skanes AC; Healey JS; Cairns JA; Dorian P; Gillis AM; McMurtry MS; Mitchell LB; Verma A; Nattel S;
    Can J Cardiol; 2012; 28(2):125-36. PubMed ID: 22433576
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antithrombotic therapy in primary and secondary stroke prevention of cardiac patients and in acute stroke].
    Csiba L; Kovács KR
    Orv Hetil; 2009 Feb; 150(5):195-202. PubMed ID: 19158017
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Epidemiology of Atrial Fibrillation and Stroke.
    Pistoia F; Sacco S; Tiseo C; Degan D; Ornello R; Carolei A
    Cardiol Clin; 2016 May; 34(2):255-68. PubMed ID: 27150174
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Critical appraisal of network meta-analyses evaluating the efficacy and safety of new oral anticoagulants in atrial fibrillation stroke prevention trials.
    Cope S; Clemens A; Hammès F; Noack H; Jansen JP
    Value Health; 2015 Mar; 18(2):234-49. PubMed ID: 25773559
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk stratification for stroke in atrial fibrillation: a critique.
    Killu AM; Granger CB; Gersh BJ
    Eur Heart J; 2019 Apr; 40(16):1294-1302. PubMed ID: 30508086
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary prevention of ischaemic stroke in atrial fibrillation: new oral anticoagulant drugs for all?
    Foley J; Kirchhof P; Lip GY
    Curr Vasc Pharmacol; 2014 May; 12(3):373-83. PubMed ID: 24846226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stroke prevention in atrial fibrillation: an update on current management strategies.
    Hall T; Stanton T; Wang WY; Ng AC
    Panminerva Med; 2013 Mar; 55(1):43-58. PubMed ID: 23474663
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stroke prevention in atrial fibrillation: do we still need warfarin?
    Diener HC; Weber R; Lip GY; Hohnloser SH
    Curr Opin Neurol; 2012 Feb; 25(1):27-35. PubMed ID: 22143201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Who gets stroke prevention? Stroke prevention in atrial fibrillation patients in the inpatient setting.
    Gallagher R; Roach K; Sadler L; Belshaw J; Kirkness A; Zhang L; Proctor R; Neubeck L
    Heart Lung Circ; 2015 May; 24(5):488-94. PubMed ID: 25613238
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiology, risk factors for stroke, and management of atrial fibrillation in China.
    Hu D; Sun Y
    J Am Coll Cardiol; 2008 Sep; 52(10):865-8. PubMed ID: 18755352
    [No Abstract]   [Full Text] [Related]  

  • 38. Atrial fibrillation and stroke management: present and future.
    Holmes DR
    Semin Neurol; 2010 Nov; 30(5):528-36. PubMed ID: 21207345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Formulating a More Comprehensive Stroke-Risk Evaluation Scale.
    Basu Ray I; Shah SK
    Tex Heart Inst J; 2018 Jun; 45(3):168-171. PubMed ID: 30072855
    [No Abstract]   [Full Text] [Related]  

  • 40. Primary and secondary stroke prevention in nonrheumatic atrial fibrillation by oral anticoagulation.
    Stöllberger C; Finsterer J
    Eur Neurol; 2003; 50(3):127-35. PubMed ID: 14530617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.